An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...

The rejiggered committee met for the first time Wednesday. Unfortunately for Kennedy’s goals, the very first presentation it heard from CDC scientists involved the safety of the COVID-19 vaccine, ...

As fired and retired scientists rallied outside in the Atlanta heat, an advisory panel that Robert F. Kennedy Jr. handpicked ...

It's a shot in the arm for Cambridge, Massachusetts-based Moderna as it faces an evolving regulatory environment for vaccines ...

Legislative changes in states like Maine and Colorado aim to protect vaccine access and adapt to federal policy shifts ...

A group of northeastern states, including Maine, New York, Rhode Island and Connecticut, are considering forming the group to ...

Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...

RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

It's related to the omicron variant and is spreading in the U.S. now, causing more than 40% of Covid-19 cases.

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the ...

The most powerful public health official in the US is reviled by some medics - but even some of his critics accept that he is ...

It’s a question laid to rest years ago, as studies showed no evidence that the preservative causes any health problems.